Peyrin-Biroulet, L. et al. Risankizumab versus ustekinumab for moderate-to-severe Crohn’s disease. N. Engl. J. Med. 391, 213–223 (2024).

Article  CAS  PubMed  Google Scholar 

Noor, N. M. et al. A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn’s disease (PROFILE): a multicentre, open-label randomised controlled trial. Lancet Gastroenterol. Hepatol. 9, 415–427 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carasso, S. et al. Inflammation and bacteriophages affect DNA inversion states and functionality of the gut microbiota. Cell Host Microbe 32, 322–334.E9 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Torres, J. et al. ECCO guidelines on therapeutics in Crohn’s disease: medical treatment. J. Crohns Colitis 14, 4–22 (2020).

Article  PubMed  Google Scholar 

Narula, N. et al. Comparative effectiveness of biologics for endoscopic healing of the ileum and colon in Crohn’s disease. Am. J. Gastroenterol. 117, 1106–1117 (2022).

Article  CAS  PubMed  Google Scholar 

Panaccione, R. et al. Efficacy and safety of guselkumab therapy in patients with moderately to severely active Crohn’s disease: results of the galaxi 2 & 3 phase 3 studies. Gastroenterology 166, 1057b1052 (2024).

Article  Google Scholar 

Jairath, V. et al. OP35 efficacy of mirikizumab in comparison to ustekinumab in patients with moderate to severe Crohn’s disease: results from the phase 3 VIVID 1 study. J. Crohns Colitis 18, i62–i64 (2024).

Article  Google Scholar 

Krinos, C. M. et al. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature 414, 555–558 (2001).

Article  CAS  PubMed  Google Scholar 

Mazmanian, S. K., Round, J. L. & Kasper, D. L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620–625 (2008).

Article  CAS  PubMed  Google Scholar 

Gordon, H. et al. ECCO guidelines on therapeutics in Crohn’s disease: medical treatment. J. Crohns Colitis 18, 1531–1555 (2024).

Article  PubMed  Google Scholar